MinichMacGregor Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
MinichMacGregor Wealth Management's MRNA Position: Q4 2023 in Review
MinichMacGregor Wealth Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 2,035 shares — an estimated $210K sold.
MinichMacGregor Wealth Management first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $313K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.
- MinichMacGregor Wealth Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
- MinichMacGregor Wealth Management sold 2,035 Moderna shares in Q4 2023, an estimated $210K.
- MinichMacGregor Wealth Management first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
- MinichMacGregor Wealth Management's Moderna position peaked at $313K in Q1 2023.
- 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.
Based on MinichMacGregor Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.